Longitudinal genome-wide DNA methylation analysis uncovers persistent early-life DNA methylation changes.
Aging
DNA methylation
Epigenetics
Histone modification
Longitudinal
Newborn
Journal
Journal of translational medicine
ISSN: 1479-5876
Titre abrégé: J Transl Med
Pays: England
ID NLM: 101190741
Informations de publication
Date de publication:
09 01 2019
09 01 2019
Historique:
received:
14
12
2018
accepted:
17
12
2018
entrez:
11
1
2019
pubmed:
11
1
2019
medline:
9
4
2020
Statut:
epublish
Résumé
Early life is a period of drastic epigenetic remodeling in which the epigenome is especially sensitive to extrinsic and intrinsic influence. However, the epigenome-wide dynamics of the DNA methylation changes that occur during this period have not been sufficiently characterized in longitudinal studies. To this end, we studied the DNA methylation status of more than 750,000 CpG sites using Illumina MethylationEPIC arrays on 33 paired blood samples from 11 subjects at birth and at 5 and 10 years of age, then characterized the chromatin context associated with these loci by integrating our data with histone, chromatin-state and enhancer-element external datasets, and, finally, validated our results through bisulfite pyrosequencing in two independent longitudinal cohorts of 18 additional subjects. We found abundant DNA methylation changes (110,726 CpG sites) during the first lustrum of life, while far fewer alterations were observed in the subsequent 5 years (460 CpG sites). However, our analysis revealed persistent DNA methylation changes at 240 CpG sites, indicating that there are genomic locations of considerable epigenetic change beyond immediate birth. The chromatin context of hypermethylation changes was associated with repressive genomic locations and genes with developmental and cell signaling functions, while hypomethylation changes were linked to enhancer regions and genes with immunological and mRNA and protein metabolism functions. Significantly, our results show that genes that suffer simultaneous hyper- and hypomethylation are functionally distinct from exclusively hyper- or hypomethylated genes, and that enhancer-associated methylation is different in hyper- and hypomethylation scenarios, with hypomethylation being more associated to epigenetic changes at blood tissue-specific enhancer elements. These data show that epigenetic remodeling is dramatically reduced after the first 5 years of life. However, there are certain loci which continue to manifest DNA methylation changes, pointing towards a possible functionality beyond early development. Furthermore, our results deepen the understanding of the genomic context associated to hyper- or hypomethylation alterations during time, suggesting that hypomethylation of blood tissue-specific enhancer elements could be of importance in the establishment of functional states in blood tissue during early-life.
Sections du résumé
BACKGROUND
Early life is a period of drastic epigenetic remodeling in which the epigenome is especially sensitive to extrinsic and intrinsic influence. However, the epigenome-wide dynamics of the DNA methylation changes that occur during this period have not been sufficiently characterized in longitudinal studies.
METHODS
To this end, we studied the DNA methylation status of more than 750,000 CpG sites using Illumina MethylationEPIC arrays on 33 paired blood samples from 11 subjects at birth and at 5 and 10 years of age, then characterized the chromatin context associated with these loci by integrating our data with histone, chromatin-state and enhancer-element external datasets, and, finally, validated our results through bisulfite pyrosequencing in two independent longitudinal cohorts of 18 additional subjects.
RESULTS
We found abundant DNA methylation changes (110,726 CpG sites) during the first lustrum of life, while far fewer alterations were observed in the subsequent 5 years (460 CpG sites). However, our analysis revealed persistent DNA methylation changes at 240 CpG sites, indicating that there are genomic locations of considerable epigenetic change beyond immediate birth. The chromatin context of hypermethylation changes was associated with repressive genomic locations and genes with developmental and cell signaling functions, while hypomethylation changes were linked to enhancer regions and genes with immunological and mRNA and protein metabolism functions. Significantly, our results show that genes that suffer simultaneous hyper- and hypomethylation are functionally distinct from exclusively hyper- or hypomethylated genes, and that enhancer-associated methylation is different in hyper- and hypomethylation scenarios, with hypomethylation being more associated to epigenetic changes at blood tissue-specific enhancer elements.
CONCLUSIONS
These data show that epigenetic remodeling is dramatically reduced after the first 5 years of life. However, there are certain loci which continue to manifest DNA methylation changes, pointing towards a possible functionality beyond early development. Furthermore, our results deepen the understanding of the genomic context associated to hyper- or hypomethylation alterations during time, suggesting that hypomethylation of blood tissue-specific enhancer elements could be of importance in the establishment of functional states in blood tissue during early-life.
Identifiants
pubmed: 30626398
doi: 10.1186/s12967-018-1751-9
pii: 10.1186/s12967-018-1751-9
pmc: PMC6327427
doi:
Substances chimiques
Chromatin
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
15Subventions
Organisme : Ministerio de Ciencia, Innovación y Universidades
ID : PI14/01781
Pays : International
Organisme : Ministerio de Ciencia, Innovación y Universidades
ID : PI11/00144
Pays : International
Organisme : Plan Nacional de I+D+I 2013-2016/FEDER
ID : PI15/00892
Pays : International
Organisme : Ministerio de Economía, Industria y Competitividad, Gobierno de España
ID : FJCI-2015-26965
Pays : International
Références
J Pediatr. 1967 Aug;71(2):159-63
pubmed: 6029463
Epigenetics. 2011 Sep 1;6(9):1085-94
pubmed: 21814035
Genome Biol. 2013 Mar 12;14(3):R21
pubmed: 23497655
Leukemia. 2002 Oct;16(10):1896-905
pubmed: 12357341
Epigenetics. 2012 Jun 1;7(6):594-605
pubmed: 22522910
Genome Biol. 2016 Oct 7;17(1):208
pubmed: 27717381
Bioinformatics. 2014 Feb 01;30(3):428-30
pubmed: 24336642
Bioinformatics. 2016 Jan 15;32(2):286-8
pubmed: 26424855
Semin Cell Dev Biol. 2005 Feb;16(1):117-28
pubmed: 15659346
Epigenetics. 2013 Feb;8(2):203-9
pubmed: 23314698
PLoS Genet. 2015 Feb 18;11(2):e1004996
pubmed: 25692570
Genes Brain Behav. 2013 Nov;12(8):792-801
pubmed: 24024963
J Transl Med. 2016 Jun 03;14(1):160
pubmed: 27259700
Genome Med. 2013 Oct 18;5(10):96
pubmed: 24134860
Bioinformatics. 2013 Jan 15;29(2):189-96
pubmed: 23175756
Bioinformatics. 2012 Mar 15;28(6):882-3
pubmed: 22257669
Nutr Metab Cardiovasc Dis. 2008 Dec;18(10):651-8
pubmed: 19013779
BMC Bioinformatics. 2012 May 08;13:86
pubmed: 22568884
Nucleic Acids Res. 2016 Feb 18;44(3):e20
pubmed: 26384415
Nat Rev Genet. 2018 Jun;19(6):371-384
pubmed: 29643443
Nat Biotechnol. 2010 Oct;28(10):1045-8
pubmed: 20944595
J Clin Invest. 2014 Jan;124(1):24-9
pubmed: 24382386
Bioinformatics. 2014 May 15;30(10):1363-9
pubmed: 24478339
Adv Immunol. 2014;121:191-211
pubmed: 24388216
Genome Biol. 2013;14(9):R102
pubmed: 24034465
Cell. 2013 Jul 3;154(1):11-3
pubmed: 23827668
J Pediatr. 1979 Nov;95(5 Pt 1):769-74
pubmed: 490248
Nat Rev Genet. 2017 Nov;18(11):643-658
pubmed: 28804139
Mol Cell. 2013 Mar 7;49(5):825-37
pubmed: 23473601
Nat Rev Genet. 2016 Oct;17(10):585-600
pubmed: 27573372
Nat Rev Mol Cell Biol. 2015 Oct;16(10):593-610
pubmed: 26373265
Hum Mol Genet. 2014 Mar 1;23(5):1186-201
pubmed: 24163245
Epigenomics. 2017 May;9(5):757-768
pubmed: 28517979
Aging Cell. 2018 Jun;17(3):e12744
pubmed: 29504244
Bioinformatics. 2016 Dec 1;32(23):3543-3551
pubmed: 27515742
Nat Biotechnol. 2010 Oct;28(10):1057-68
pubmed: 20944598
Bioinformatics. 2016 Feb 15;32(4):587-9
pubmed: 26508757
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
PLoS Genet. 2015 Jan 29;11(1):e1004958
pubmed: 25634236
Nat Biotechnol. 2016 Jul;34(7):726-37
pubmed: 27347756
Nat Rev Genet. 2012 Jan 04;13(2):97-109
pubmed: 22215131
PLoS One. 2011;6(7):e21800
pubmed: 21789182
Nucleic Acids Res. 2013 Apr;41(7):e90
pubmed: 23476028
Genome Biol. 2013 May 22;14(5):R42
pubmed: 23697701
Nature. 2012 Sep 6;489(7414):57-74
pubmed: 22955616
Bioessays. 2017 Jul;39(7):
pubmed: 28590035
Cell. 2008 Sep 19;134(6):921-31
pubmed: 18805086
BMC Bioinformatics. 2010 Nov 30;11:587
pubmed: 21118553
Bioinformatics. 2015 Jul 15;31(14):2382-3
pubmed: 25765347
Genome Res. 2012 Apr;22(4):623-32
pubmed: 22300631
Mol Aspects Med. 2013 Jul-Aug;34(4):765-81
pubmed: 22771540
Clin Epigenetics. 2015 Mar 26;7:34
pubmed: 25874017
Hum Mol Genet. 2015 Jul 1;24(13):3752-63
pubmed: 25869828
PLoS Genet. 2007 Sep;3(9):1724-35
pubmed: 17907809
Nat Rev Genet. 2012 May 29;13(7):484-92
pubmed: 22641018
Genome Res. 2015 Jan;25(1):27-40
pubmed: 25271306
Bioinformatics. 2008 Jul 1;24(13):1547-8
pubmed: 18467348